QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety

NCT04233151 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: QL1203
DRUG: Placebo
DRUG: mFOLFOX6 regimen

Sponsor

Qilu Pharmaceutical Co., Ltd.